510(k) Report

510(k) · Cleared

Cleared

Cellfina System

K150505510(k) TraditionalCleared Jul 29, 2015154-day reviewClass II21 CFR 878.4790

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ulthera, Inc. · OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite

Cleared on Jul 29, 2015 as substantially equivalent to K134010 (Cabochon Aesthetics, Inc., 2014) after a 154-day review. Its family tree reaches back 2 generations to 2013. 6 later devices descend from it.

Decided
Jul 29, 2015
Review
154 days
Class
Class II
Product code
OUP
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN110004 (2013). 6 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2016: 2 descendants cleared2019: 1 descendant cleared2021: 1 descendant cleared2022: 1 descendant cleared2023: 1 descendant clearedDEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 2013K134010 · Cabochon System · Cabochon Aesthetics, Inc. · 20142010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant5 generations forward: 1 descendant6 generations forward: 1 descendant K134010 · Cabochon System · Cabochon Aesthetics, Inc. · 2014DEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 20130+5
  1. Root · 2 generations backDEN110004 Cabochon SystemCabochon Aesthetics, Inc. · 2013
  2. 1 generation backK134010 Cabochon SystemCabochon Aesthetics, Inc. · 2014
  3. This deviceK150505 Cellfina SystemUlthera, Inc. · 2015
  4. Descendant · cites it directly · 5 of its ownK153677 The Cellfina SystemUlthera, Inc. · 2016
  5. Descendant · 2 generations on · 4 of its ownK161885 The Cellfina SystemUlthera, Inc. · 2016 · Recalled
  6. Descendant · 3 generations on · 3 of its ownK192185 The Cellfina SystemUlthera, Inc. · 2019
  7. Descendant · 4 generations on · 2 of its ownK212399 AveliNc8, Inc. · 2021
  8. Descendant · 5 generations on · 1 of its ownK221336 AvéliRevelle Aesthetics, Inc. · 2022

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2016: 22019: 12021: 12022: 12023: 1
2016high 2 (2016) · low 0 (2017)2026

Most influential descendants

Showing 5 of 6 · See all
  • K153677The Cellfina SystemUlthera, Inc. · 2016 · cites it directly5descendants
  • K161885The Cellfina SystemUlthera, Inc. · 2016 · 2 generations on4descendants
  • K192185The Cellfina SystemUlthera, Inc. · 2019 · 3 generations on3descendants
  • K212399AveliNc8, Inc. · 2021 · 4 generations on2descendants
  • K221336AvéliRevelle Aesthetics, Inc. · 2022 · 5 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN110004Cabochon SystemCabochon Aesthetics, Inc.2013—
−1K134010Cabochon SystemCabochon Aesthetics, Inc.2014—
0 (this device)K150505Cellfina SystemUlthera, Inc.2015—
+1K153677The Cellfina SystemUlthera, Inc.2016—
+2K161885The Cellfina SystemUlthera, Inc.20161
+3K192185The Cellfina SystemUlthera, Inc.2019—
+4K212399AveliNc8, Inc.2021—
+5K221336AvéliRevelle Aesthetics, Inc.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201620
201910
202110
202210
202310
FIG. 1 — Lineage of K150505, 2013–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OUP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OUP device

  1. #1 K221336 Avéliscore 8.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K134010Cabochon System
Summary page 4
…Code: OUP  LegallyMarketedPredicate: CellfinaSystem (tradenamepreviouslyCabochonSystem), 510(k): K134010  ApplicableGuidance: The following guidance special controls are applicable to the Cellfina…
Cabochon Aesthetics, Inc.2014—

What descends from it? (6)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K153677The Cellfina SystemUlthera, Inc.20165

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 2 companies; a new generation was cleared every 1.3 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K153677 (Ulthera, Inc., 2016) has gone furthest, with 5 descendants of its own.

How does its category compare?

All OUP devices

OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · OUP

1in 2023

2013: 12014: 12015: 12016: 22019: 12021: 12022: 12023: 1
2007high 2 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OUP

Too few OUP 510(k)s in any year since 2007 to give a median.

Recalls per year · OUP

1in 2016

2016: 1
2007high 1 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OUP

4in 2025

2016: 32017: 42018: 82019: 162020: 32021: 92022: 152023: 112024: 62025: 4
2007high 16 (2019) · low 0 (2007)2025

MAUDE reports naming product code OUP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—00
20151—00
20162—13
20170—04
20180—08
20191—016
20200—03
20211—09
20221—015
20231—011
20240—06
20250—04
20260—0—

What is it indicated for?

The Cellfina™ System is intended for long term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating no significant reduction in treatment benefits up to 2 years of observation.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K150505: Cellfina System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150505

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026